Oramed PharmaceuticalsORMP
那斯達克 · USD
3.25
+0.08
(+2.52%)
收盤 02/14 04:54 (UTC+8)
02/14 04:54 (UTC+8)
Oramed PharmaceuticalsORMP
3.25
+0.08
(+2.52%)
財務數據
損益表
- 0.01
- -
- -
- -
- -
- -
- -
- 0.02
- -
- -
- 1.20
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | - | - | 2,000 | - | - | - | - | - | - | 674 |
營業成本 | - | - | 1,987 | - | - | - | - | - | - | - |
營業毛利 | - | - | 13 | - | - | - | - | - | - | 674 |
營業費用 | 2,427 | 2,489 | 4,513 | 3,595 | 3,089 | 3,135 | 2,962 | 3,877 | 2,893 | 4,465 |
研發費用 | 1,153 | 1,034 | 2,206 | 1,461 | 2,242 | 1,442 | 1,179 | 1,766 | 957 | 1,821 |
推銷及管理費用 | 1,274 | 1,455 | 2,307 | 2,134 | 847 | 1,693 | 1,783 | 2,111 | 1,936 | 2,644 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -2,427 | -2,489 | -4,500 | -3,595 | -3,089 | -3,135 | -2,962 | -3,877 | -2,893 | -3,791 |
其他收入及費用 | -12,400 | - | - | -2,286 | - | - | 5,088 | - | 435 | 2,478 |
利息費用 | - | - | - | - | - | 261 | 592 | 1,211 | 826 | - |
稅前純益 | 59,451 | 13,134 | -7,058 | -9,783 | -18,509 | 10,838 | 1,534 | 13,296 | -3,284 | -1,313 |
所得稅 | 11,062 | -126 | 584 | 416 | 1,133 | 1,634 | - | - | - | - |
稅後純益 | 48,395 | 13,288 | -7,642 | -10,232 | -19,619 | 9,212 | 1,536 | 12,899 | -3,222 | -1,194 |
基本每股稅後盈餘(元) | 1.16 | 0.32 | -0.19 | -0.26 | -0.48 | 0.22 | 0.04 | - | -0.08 | -0.03 |
稀釋每股稅後盈餘(元) | 1.13 | 0.31 | -0.19 | -0.26 | -0.48 | 0.22 | 0.04 | 0.33 | -0.08 | -0.03 |
基本平均股數(千股) | 41756.00 | 41743.00 | 41228.00 | 40623.00 | 40896.00 | 40959.00 | 40835.00 | - | 40445.00 | 40225.00 |
稀釋平均股數(千股) | 42774.00 | 42609.00 | 41228.00 | 39262.00 | 40896.00 | 41591.00 | 41564.00 | - | 40445.00 | 40225.00 |
還原基本每股稅後盈餘(元) | 1.16 | 0.32 | -0.19 | -0.26 | -0.48 | 0.22 | 0.04 | - | -0.08 | -0.03 |
還原稀釋每股稅後盈餘(元) | 1.13 | 0.31 | -0.19 | -0.26 | -0.48 | 0.22 | 0.04 | 0.33 | -0.08 | -0.03 |
還原基本平均股數(千股) | 41,756 | 41,743 | 41,228 | 40,623 | 40,896 | 40,959 | 40,835 | - | 40,445 | 40,225 |
還原稀釋平均股數(千股) | 42,774 | 42,609 | 41,228 | 39,262 | 40,896 | 41,591 | 41,564 | - | 40,445 | 40,225 |
EBITDA(千元) | 59,488 | 13,192 | -7,028 | -9,785 | -18,434 | 11,161 | 2,184 | 14,163 | -2,342 | -1,142 |